{
  "id": 11122,
  "url": "https://www.ft.com/content/72c335dd-11c9-4ba0-bd11-41414df06d97?syn-25a6b1a6=1",
  "title": "Dassault Systèmes in talks to buy drug trial software company for about $2bn",
  "summary": "Potential purchase of ArisGlobal from Swedish buyout group would boost French conglomerate’s push into life sciences",
  "authors": null,
  "category": "news",
  "topics": "healthcare",
  "orgs": null,
  "regions": null,
  "published_at": "2026-07-16T18:12:05.000Z",
  "fetched_at": "2026-07-17T05:10:53.887Z",
  "source_slug": "x-financial-times-technology-headlines",
  "source_name": "Financial Times Technology (headlines)",
  "source_homepage": "https://www.ft.com/technology",
  "ethics_ai_record_url": "https://ethics.ai/record/11122",
  "original_url": "https://www.ft.com/content/72c335dd-11c9-4ba0-bd11-41414df06d97?syn-25a6b1a6=1",
  "evidence_status": "source-only",
  "attribution": "via ethics.ai"
}